ERS 2017 International Congress, Programme

You can now submit sessions for the 2017 ERS Congress.  Learn more about the 2017 priority topics.

Challenging clinical case

Meet the expert

Postgraduate course

Case-based sessions allow participants to understand the history, pathology, analysis and treatment of complex clinical cases in different subject areas. The session leader, along with two case presenters, will encourage and facilitate a discussion in order to examine and discuss each case. Participants are encouraged to actively participate in the session and to provide their own difficult case examples to present onsite. Registration for these sessions is additional to the congress registration fee.

An expert is on hand to stimulate discussion, answer questions and offer advice. The format encourages a more personal approach to learning. Each of the lunchtime expert sessions are limited to 50 participants. Registration for these sessions is additional to the congress registration fee.

The courses aim to improve knowledge and skills that will be applied in the daily practice of clinicians, respiratory scientists and healthcare professionals. The information disseminated during the course should introduce the basic concepts and established practices rather than scientific work in progress. Registration for these courses is additional to the congress registration fee.

Skills workshop

Symposium

Professional development

The workshops are designed to allow participants to gain practical skills in different disciplines of respiratory medicine. The workshops will revolve around 4 workstations and use interactive demonstrations and equipment instead of traditional presentations and lectures. Registration for these workshops is additional to the congress registration fee.

In these 2-hour long sessions four renowned experts present state of the art reviews on all aspects of respiratory medicine, or topics of interest to respiratory professionals. Each symposium is chaired by two specialists in the presented topic. Symposia are open to all Congress delegates.

Professional development activities aim to provide participants with practical tips and guidelines on how to be more well-rounded health professionals. If you have ideas on please contact the programme team
This email address is being protected from spambots. You need JavaScript enabled to view it. by
4 April 2016.

Hot Topic

Grand Round

Year in Review

These sessions cover the latest developments in respiratory medicine or in topics of interest to respiratory professionals. Each hot topic session is chaired by two specialists in the presented topic. They are open to all Congress delegates.

Submission possible from December 2016

Grand rounds are interactive sessions, where cases of interest to a wide audience are presented and well documented. The audience will be solicited to give by vote an opinion at each step of the diagnostic and therapeutic procedures. They are open to all Congress delegates.

Submission possible from December 2016

The Year in Review sessions aim at providing an overview of what was recently published, discovered, on a specific topic. Recurrent topics for Year in Review Sessions are: Clinical, Paediatric, Scientific. They are open to all Congress delegates.

Submission possible from December 2016

The ERS Congress Programme Committee encourages you to develop a session that includes faculty members of varying ages, backgrounds, specialties and gender.

Please contact This email address is being protected from spambots. You need JavaScript enabled to view it. should you require more information about submitting proposals for the 2017 Congress.

2017 Assembly topic priorities

The 11 ERS assemblies have identified the following priority subject areas and would like to welcome you to submit proposals. 

Assembly

Topics

1. Clinical
  • Interstitial lung diseases
  • CT for pneumologists
  • Clinical problems solving
  • Interventional pulmonology
  • Sarcoidosis
  • Biopsy options
  • Lung cancer screening
2. Respiratory intensive care
  • NIV vs. HFNC for hypoxemic patients
  • Expanding NIV indication for weaning purposes: patient populations, modes of ventilation, interfaces, sedatives)
  • Long term mechanical ventilation in COPD: which markers should we consider? How should we monitor? Where should we start it?
  • Beyond flow, volume and airway pressure: which signals should we consider today for the ventilatory management of critically-ill patients
  • Bedside imaging of the critically ill patient
  • Weaning ten years later: are the statements of the Sixth International Consensus Conference on Intensive Care Medicine about Weaning still valid?
  • Non-invasive ventilation vs. High Flow Nasal Cannula
  • Hospital-acquired and ICU-acquired pneumonia
  • What outcome for mechanically ventilated patients?
3. Cell and molecular biology
  • Immunity and the Lung
  • The Lung Microbiome
  • Stem Cells in Lung Diseases
  • Lung Matrix
  • Emphysema
4. Clinical physiology, sleep and pulmonary circulation
  • New paradigms in the diagnosis of sleep apnoea
  • Interaction of sleep apnoea and respiratory failure
  • Deleterious/protective effects of intermittent hypoxia in OSA
  • From brain to cardiopulmonary interaction passing through locomotor muscles: the origin and mechanisms of exertional dyspnoea in cardiorespiratory diseases
  • Respiratory muscle at rest and during exercise: What's new?
  • Mild COPD: physiology, clinical implications, treatment....where are we?
  • Respiratory muscle testing: an update
5. Airway diseases
  • Immunity in asthma and COPD
  • Eosinophili inflammation in COPD
  • Non-invasive assessment of airway inflammation
  • Pharmacological treatment in bronchiectasis
  • Personalised medicine in airway disease
  • Blood eosinophilia in COPD
  • Non-invasive technique to assess airway inflammation
  • ICS in COPD: how, when, why
  • Chronic cough and eosinophili bronchitis
6. Occupation and epidemiology
  • Lung cancer screening
  • Microbiota and lung disease
  • Smoking cessation
  • Statistical methods in epidemiology
  • Gene-environment interactions and the individual patient
  • Prediction rules for asthma and COPD
  • The respiratory microbiome and the environment
  • How can we keep individuals with respiratory disease at work
7. Paediatrics
  • Bronchiolitis and preschool wheezing
  • Asthma
  • Microbioma in respiratory infections
  • Lung Function Tests
  • Non-CF bronchiectasis and PCD
  • Acute and chronic respiratory infection
8. Thoracic surgery and transplantation
  • Difficult lung transplant indications
  • Donors for lung transplantation in 2017: where are we?
  • Lung transplantation and cancer
  • Difficult pulmonary infections: what have we learned from lung transplantation?
  • Key points of the preoperative selection for marginal surgical candidates
  • What is the optimal multimodality treatment for lung cancer?
  • Medistinal problems
  • Mesothelioma
  • Pneumothorax
  • Bronchiectasis - localised form
  • Undetermined lung nodules
9. Allied respiratory professionals
  • Relevant outcomes to measure in chronic disease management
  • Pulmonary rehabilitation
  • New techniques in diagnosing respiratory diseases
  • Self-management in respiratory disease
  • Muscle function and structure in COPD
  • Care models for chronic lung disease
10. Respiratory infections
  • Pneumonia
  • Antimicrobial resistance
  • New anti-TB drugs
  • Influenza and viral infections
  • New diagnostics, including whole genome sequencing, for the TB diagnosis
  • LTBI
  • Challenges in LTBI management
  • Microbial phenotypes in chronic airway diseases
  • Clinical impact of NTM
  • Global perspective on ILI
  • New and repurposed anti-TB drugs
11. Thoracic oncology
  • Update on immuno-therapies and its combinations with standard therapies in lung cancer
  • Rational diagnostic work-up of lung cancer at the time of first diagnosis and relapse – What do we need to know to treat our patients and how do we get the needed information? - Interventional techniques
  • Rational diagnostic work-up of lung cancer at the time of first diagnosis and relapse – What do we need to know to treat our patients and how do we get the needed information? - Molecular pathology
  • The new TNM-staging system and beyond – predicting lung cancer prognosis
  • Rational diagnostic work-up of lung cancer at the time of first diagnosis and relapse – What do we need to know to treat our patients and how do we get the needed information? - Imaging techniques
  • Update on malignant pleural mesothelioma
  • Early integration of palliative care in thoracic oncology patients – has the goal been really achieved yet?
  • How to evaluate fitness for therapy in lung cancer patients and how to follow them up after surgery, radiotherapy and/or chemotherapy
  • Early integration of palliative care for lung cancer patients
  • Deliver bad news
  • Immunotherapy in interaction with Anti-VEGF stategies
  • Therapeutic sequences for lung cancer treatment
  • Infectious and immunological complications during lung cancer treatment